Skip to main content

Edwards Lifesciences Corp Europe revenue

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

Europe revenue at Edwards Lifesciences Corp came to $414.6M for the quarter to 30 Sep 2026, up 6.9% from a year earlier.

As Edwards Lifesciences Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$302.2MDec 2023$326.0MMar 2024$332.2MJun 2024$319.8MSep 2024$343.7MDec 2024$341.8MMar 2025$378.2MJun 2025$387.9MSep 2025$409.6MDec 2025$442.6MMar 2026$439.6MJun 2026$414.6MSep 2026
Edwards Lifesciences Corp Europe revenue, every reported period
Period endingEurope revenueChange on a yearFiled
30 Sep 2026$414.6Mup 6.9%4 Nov 2026
30 Jun 2026$439.6Mup 16.2%4 Aug 2026
31 Mar 2026$442.6Mup 29.5%6 May 2026
31 Dec 2025$409.6Mup 19.2%25 Feb 2026
30 Sep 2025$387.9Mup 21.3%5 Nov 2025
30 Jun 2025$378.2Mup 13.8%6 Aug 2025
31 Mar 2025$341.8Mup 4.8%6 May 2025
31 Dec 2024$343.7Mup 13.7%28 Feb 2025
30 Sep 2024$319.8Mup 13.1%6 Nov 2024
30 Jun 2024$332.2Mup 10.0%31 Jul 2024
31 Mar 2024$326.0Mdown 2.8%29 Apr 2024
31 Dec 2023$302.2Mdown 3.1%12 Feb 2024
30 Sep 2023$282.7Mdown 3.2%27 Oct 2023
30 Jun 2023$302.0Mdown 2.5%28 Jul 2023
31 Mar 2023$335.4Mup 11.8%28 Apr 2023
31 Dec 2022$311.9Mup 6.3%13 Feb 2023
30 Sep 2022$291.9Mup 8.6%28 Oct 2022
30 Jun 2022$309.8Mup 9.9%29 Jul 2022
31 Mar 2022$300.1Mup 17.5%28 Apr 2022
31 Dec 2021$293.5Mup 17.7%14 Feb 2022
30 Sep 2021$268.9Mup 11.3%29 Oct 2021
30 Jun 2021$281.8Mup 36.2%30 Jul 2021
31 Mar 2021$255.4Mup 3.2%28 Apr 2021
31 Dec 2020$249.3Mup 3.1%12 Feb 2021
30 Sep 2020$241.5Mup 9.9%26 Oct 2020
30 Jun 2020$206.9Mdown 12.8%27 Jul 2020
31 Mar 2020$247.5Mup 8.9%28 Apr 2020
31 Dec 2019$241.8Mup 10.8%14 Feb 2020
30 Sep 2019$219.8Mup 14.7%25 Oct 2019
30 Jun 2019$237.2Mup 12.3%26 Jul 2019
31 Mar 2019$227.3Mup 10.7%26 Apr 2019
31 Dec 2018$218.3M—15 Feb 2019
30 Sep 2018$191.6Mup 14.2%26 Oct 2018
30 Jun 2018$211.2Mup 16.6%27 Jul 2018
31 Mar 2018$205.3M—27 Apr 2018
30 Sep 2017$167.8M—27 Oct 2017
30 Jun 2017$181.2M—28 Jul 2017
30 Jun 2013$160.7Mup 6.8%6 Aug 2013
31 Mar 2013$155.5Mup 3.1%6 May 2013
31 Dec 2012$146.1Mup 4.1%28 Feb 2013

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Edwards Lifesciences Corp: Transcatheter Aortic Valve Replacement revenue · Surgical revenue · Transcatheter Mitral and Tricuspid Therapies revenue · United States revenue · Rest of World revenue · Japan revenue · financial statements

Every KPI and segment of EW, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.